Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2017-02-20 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly corresponds to the company repurchasing or selling its own shares. The relevant filing type is 'Transaction in Own Shares' (POS). Although it mentions reading the full announcement in PDF, the core content is the transaction detail, making POS more specific than RPA or RNS.
2017-02-20 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 99% confidence The document explicitly discusses 'Transactions under Novozymes' stock buyback program' and provides detailed tables showing the number of shares purchased, average price, and transaction value over several days in February 2017. This content directly relates to the company repurchasing its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a detailed report of these transactions, not merely an announcement of a report's publication.
2017-02-20 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement (Selskabsmeddelelse nr. 11) detailing the specific transactions of Novozymes' share buyback program over a one-week period. It includes aggregate data, a summary table, and a detailed appendix of individual trade executions. This fits the definition of 'Transaction in Own Shares' (POS), as it reports the company buying back its own shares in accordance with regulatory requirements (Market Abuse Regulation).
2017-02-20 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 95% confidence The document is a brief announcement stating that Novozymes has bought back 553,000 shares under its share buyback program, providing transaction value and program start date. This directly matches the “Transaction in Own Shares” category (share repurchase activity).
2017-02-20 Danish
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company acquiring its own shares. The filing category that matches this activity is 'Transaction in Own Shares' (POS). The document length is very short (278 chars) and mentions reading the full announcement in PDF, which might suggest RPA, but the core content is a direct report of a share transaction (buyback), making POS the most specific and accurate classification for the *content* described, even if it's a brief announcement of that transaction.
2017-02-13 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text is very short (264 characters) and explicitly states that Novozymes bought back shares under a previously announced share repurchase program ('aktietilbagekøbsprogram'). This describes a transaction involving the company's own shares. The final line, 'Læs hele meddelelsen i PDF format' (Read the full announcement in PDF format), suggests this is a brief notification, not the full detailed report. The most specific category for reporting the company buying back its own shares is 'Transaction in Own Shares' (POS).
2017-02-13 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.